Ocular Therapeutix, Inc. (OCUL)
6.50
-0.11
(-1.66%)
USD |
NASDAQ |
Oct 23, 16:00
6.495
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Price : 6.50 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 6.68 | 6.68 | 6.345 | 6.50 | 1.856M |
| Oct 22, 2026 | 6.42 | 6.665 | 6.395 | 6.61 | 2.145M |
| Oct 21, 2026 | 6.69 | 6.750 | 6.375 | 6.48 | 2.492M |
| Oct 20, 2026 | 6.30 | 6.775 | 6.30 | 6.65 | 2.617M |
| Oct 19, 2026 | 7.13 | 7.18 | 6.00 | 6.29 | 8.358M |
| Oct 16, 2026 | 7.38 | 7.39 | 6.85 | 6.87 | 2.762M |
| Oct 15, 2026 | 7.29 | 7.465 | 7.23 | 7.38 | 3.253M |
| Oct 14, 2026 | 7.14 | 7.30 | 7.07 | 7.20 | 2.209M |
| Oct 13, 2026 | 7.55 | 7.61 | 7.20 | 7.24 | 3.216M |
| Oct 12, 2026 | 7.60 | 7.75 | 7.36 | 7.56 | 3.670M |
| Oct 09, 2026 | 7.49 | 7.68 | 7.38 | 7.54 | 2.630M |
| Oct 08, 2026 | 7.20 | 7.565 | 7.06 | 7.51 | 3.901M |
| Oct 07, 2026 | 7.26 | 7.545 | 7.19 | 7.23 | 2.933M |
| Oct 06, 2026 | 7.30 | 7.565 | 7.13 | 7.34 | 2.807M |
| Oct 05, 2026 | 6.93 | 7.27 | 6.79 | 7.25 | 5.620M |
| Oct 02, 2026 | 7.40 | 7.425 | 6.935 | 6.96 | 4.958M |
| Oct 01, 2026 | 7.63 | 7.705 | 7.26 | 7.29 | 4.514M |
| Sep 30, 2026 | 7.88 | 8.159 | 7.634 | 7.67 | 4.569M |
| Sep 29, 2026 | 7.80 | 8.13 | 7.510 | 7.87 | 5.287M |
| Sep 28, 2026 | 9.38 | 9.38 | 7.18 | 7.655 | 15.44M |
| Sep 25, 2026 | 9.77 | 9.85 | 9.585 | 9.65 | 1.622M |
| Sep 24, 2026 | 9.94 | 9.98 | 9.60 | 9.82 | 1.865M |
| Sep 23, 2026 | 10.48 | 10.57 | 9.77 | 10.00 | 2.089M |
| Sep 22, 2026 | 10.08 | 10.61 | 10.02 | 10.50 | 2.495M |
| Sep 21, 2026 | 10.08 | 10.17 | 9.81 | 9.99 | 2.073M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EyePoint, Inc. | 0.4045 |
| ANI Pharmaceuticals, Inc. | 72.61 |
| Eli Lilly & Co. | 1273.46 |
| Corcept Therapeutics, Inc. | 85.86 |
| Veru, Inc. | 2.24 |
Price Related Metrics
| PS Ratio | 26.72 |
| PEG Ratio | -0.4341 |
| Price to Book Value | 2.745 |
| Earnings Yield | -21.74% |
| Market Cap | 1.427B |
| PEGY Ratio | -0.4341 |